Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Meta-analysis
100%
Randomized Controlled Trial
100%
Trauma Patients
100%
Tranexamic Acid
100%
30-day Mortality
50%
Placebo
33%
Odds Ratio
33%
Risk Reduction
16%
Exclusion Criteria
16%
Patient Outcomes
16%
Early Mortality
16%
Mortality Risk
16%
Clinical Benefit
16%
MEDLINE
16%
Pooled Analysis
16%
Hospitalized Patients
16%
Scopus
16%
Google Scholar
16%
Randomized Controlled Clinical Trial
16%
Cochrane Central Register of Controlled Trials
16%
Pooled Odds Ratios
16%
Cochrane Library
16%
RCT Study
16%
Prehospital Setting
16%
International Clinical Trials Registry Platform (ICTRP)
16%
Antifibrinolytic Agents
16%
Hospital Administration
16%
Thromboembolic Complications
16%
Severe Bleeding
16%
Nursing and Health Professions
Meta Analysis
100%
Tranexamic Acid
100%
Efficacy
100%
Odds Ratio
50%
Thromboembolism
50%
Placebo
33%
Cochrane Library
33%
Treatment Outcome
16%
Hospital Setting
16%
Systematic Review
16%
Hospital Inpatient
16%
Medline
16%
Scopus
16%
Hospital Management
16%
Bleeding
16%
Antifibrinolytic Agent
16%
World Health Organization
16%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Tranexamic Acid
100%
Thromboembolism
50%
Placebo
33%
Clinical Trial
16%
Bleeding
16%
Controlled Clinical Trial
16%
Antifibrinolytic Agent
16%